Musclepharm — Investor Presentation (March 2013)
17 slides from Musclepharm's investor presentation, Mar 14, 2013
Slide 1: Company Presentation
COMPANY PRESENTATION
Slide 2: Slide 2
Slide 3: Table of Contents
MUSCLEPHARM, MUSCLEPHARM, MUSCLEPHARM, TABLE OF CONTENTS FORWARD LOOKING STATEMENT ‘OUR COMPANY ‘OUR MANAGEMENT (MARKET ANALYSIS. INDUSTRY OVERVIEW ‘ADVISORY BOARD ‘CORPORATE OFFICE DISTRIBUTION FOOTPRINT AWARDS INNOVATION & NEW PRODUCTS (MARKETING & BRANDING STRATEGY GROWTH STRATEGY ‘COMPANY GoALS.
Slide 4: Forward Looking Statement
MUSCLEPHARM, Information included hersin contain forward looking statamants, Forward-looking statements are idantfieg by words such ag “expect, “plan,” -will” “should “could,” “anticipate, “estimato," and other similar expressions. Forward looking statements involve significant risks and uncertainti
Slide 5: Our Company
Founded in 2008, MusclePharm is a healthy liestyle company that develops and manufactures nutritional supplements that address active Hfestyles, inckading muscle building, weight loss ané maintaining general fitness thraugh'a daily nutritional supplement rogimen. We currantly have 20 products that a
Slide 6: Our Management
NP MUSCLEPHARM, MUSCLEPHARM, TP OUR MANAGEMENT Brad Pyatt- CEO/Founder/Co-Chair John Bluher EVP/COO/Co-Chaie ‘Significant Expariance in Both the Sports Nutrition and Mult Disciplinary Senior Managomant Background Exercise Sonee Fads Foundar of MusclePharm and CED, 2008 - Present Former NEL Player (7
Slide 7: Market Analysis and Industry Overview
NP MUSCLEPHARM, MARKET ANALYSIS SUMMARY ‘The market for sport nutritionals and supplements is eubstantial. Andi one of the fastest-growing ‘segments of the health supplamant markat investors can expect double digit markat growth through 20131 ‘According to BEC Research, the global market for sports
Slide 8: Advisory Board
NP MUSCLEPHARM, MUSCLEPHARM, TP MUSCLEPHARM ADVISORY BOARD | ‘UELING ae meee RSPR THLETES DIRECTOR & DEVELOPMENT AND CHIEF SCIENTIFIC FORMULATOR RESEARCH DIRECTOR > tT fo “ As Cha Formulator and Asa tstad matical (hist Medica Director Or Caungal Dr Moora ie LF Ld MourobiPaveasltrings FormerUSheotant
Slide 9: Corporate Office
MP od TE OFFICE BUILDING PERFECT ATHLETE a % ORs SPORTS SCIENCE CENTER RESEARCH INSTITUTE BM
Slide 10: Distribution Footprint
DISTRIBUTION FOOTPRINT THE ATHLETES COMPANY ed
Slide 11: GNC 2012 Vendor Awards
GNC = WELL SPORTS GNC 2012 VENDOR AWARDS ARE CREATED THROUGH AN ADVANCED PROTOCOL WHICH UTILIZES THE EXPERTISE OF TOP. NUTRITIONAL SCIENTISTS. TaN B
Slide 12: Innovation & New Products
ASSAULT ENERGY SHOTS: NITRATE SERIES: FOR CONVENIENCE STORES REVOLUTIONARY ION-3 TECHNOLOGY INNOVATION & NEW PRODUCTS INNOVATION: FEMALE ONLY FITNESS LINE UFC FIGHTSTACK: COMBINATION OF FIVE OF OUR MOST SUCCESSFUL PRODUCTS i a FIGHT 6 aT ROE
Slide 13: Marketing & Branding Strategy
NP MUSCLEPHARM, MUSCLEPHARM, IVE MARKETING & BUILT BRANDING STRATEGY THIS iP © Brand MuselePharm as the “must have fitness brand for workout enthusiasts and alte athletes. We soak tobe knawn as the athlete's company runby athletes who create their products for ‘thor athletes both professional and am
Slide 14: Growth Strategy and Company Goals
NP MUSCLEPHARM, MUSCLEPHARM, TP GROWTH STRATEGY COMPANY GOALS + nore ou product slatbutlon and alos IF YOU BUILD IT THEY WILL COME - trough iereasad markt panaratlons bath 2011 ACCOMPLISHED: ‘dmasticaly ard ntrnationali, “Bult the brand Us markatng and UEC rlaonship “Open dstabuton stannels using as
Slide 15: Sales & Margin Improvement; Capitalization Table
iP MUSCLEPHARM, SALES & MARGIN IMPROVEMENT ‘SALES & MARGIN INCREASE DISCOUNTS DROP 2008 2010 201. 2012 2013 P MIGROSSSALES DISCOUNTS PROMOS ——DISCOUNT% —E-GROSS MARGIN % ‘Not Soles (calculated in accordance with GAAP) has grown from 2008 through the third quarter of 2012 ata compound annual growth r
Slide 16: min
min vamp Va
Slide 17: MusclePharm
niR ow Bae MUSCLEPHARM,